Our perception of insulin-like growth factor-I (IGF-I) as a growth promoter stems from the original proposal of Salmon & Daughaday (1957) that it mediates the biological actions of pituitary growth hormone (GH). The primary target for GH, it was proposed, is the liver which is stimulated to synthesize IGF-I. The resultant increase in circulating levels of IGF-I promotes cell division and constitutes a major component of the growth response. There is a large body of evidence which relates serum IGF-I concentrations to growth rates; moreover, the liver is the major source of the hormone since it has the highest tissue level of IGF-I mRNA (Murphy et al. 1987) and its synthesis of IGF-I peptide can account, in theory, for the known turnover of IGF-I in the circulation (Schwander et al. 1983).
Subsequently it was shown that IGFs are synthesized to varying degrees in many other tissues. While these observations indicate
Journal of Endocrinology is committed to supporting researchers in demonstrating the impact of their articles published in the journal.
The two types of article metrics we measure are (i) more traditional full-text views and pdf downloads, and (ii) Altmetric data, which shows the wider impact of articles in a range of non-traditional sources, such as social media.
More information is on the Reasons to publish page.
| Sept 2018 onwards | Past Year | Past 30 Days | |
|---|---|---|---|
| Full Text Views | 7 | 0 | 0 |
| PDF Downloads | 3 | 0 | 0 |
Online ISSN: 1479-6805
Print ISSN: 0022-0795
Strengthening biomedical communities
to advance science and health
CONTACT US
Bioscientifica Ltd | Starling House | 1600 Bristol Parkway North | Bristol BS34 8YU | UK
Bioscientifica Ltd | Registered in England no 3190519
